As of 2024-10-08, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 679.07 USD. This relative valuation is based on P/E multiples. With the latest stock price at 996.05 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is -31.8%.
The range of the Relative Valuation is 582.95 - 757.46 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 19.3x | 18.0x |
| Forward P/E multiples | 15.9x - 19.6x | 17.8x |
| Fair Price | 582.95 - 757.46 | 679.07 |
| Upside | -41.5% - -24.0% | -31.8% |
| Date | P/E |
| 2024-10-08 | 25.64 |
| 2024-10-07 | 25.41 |
| 2024-10-04 | 25.83 |
| 2024-10-03 | 25.88 |
| 2024-10-02 | 26.53 |
| 2024-10-01 | 26.70 |
| 2024-09-30 | 26.81 |
| 2024-09-27 | 26.60 |
| 2024-09-26 | 26.53 |
| 2024-09-25 | 26.30 |
| 2024-09-24 | 26.68 |
| 2024-09-23 | 27.85 |
| 2024-09-20 | 29.21 |
| 2024-09-19 | 29.34 |
| 2024-09-18 | 29.05 |
| 2024-09-17 | 29.25 |
| 2024-09-16 | 29.41 |
| 2024-09-13 | 29.42 |
| 2024-09-12 | 29.70 |
| 2024-09-11 | 29.11 |
| 2024-09-10 | 28.98 |
| 2024-09-09 | 29.20 |
| 2024-09-06 | 28.86 |
| 2024-09-05 | 29.35 |
| 2024-09-04 | 30.08 |
| 2024-09-03 | 29.81 |
| 2024-08-30 | 30.22 |
| 2024-08-29 | 30.07 |
| 2024-08-28 | 30.59 |
| 2024-08-27 | 30.65 |
| 2024-08-26 | 30.59 |
| 2024-08-23 | 30.58 |
| 2024-08-22 | 30.29 |
| 2024-08-21 | 30.23 |
| 2024-08-20 | 30.41 |
| 2024-08-19 | 30.53 |
| 2024-08-16 | 30.08 |
| 2024-08-15 | 29.98 |
| 2024-08-14 | 29.51 |
| 2024-08-13 | 29.54 |
| 2024-08-12 | 28.59 |
| 2024-08-09 | 28.85 |
| 2024-08-08 | 28.40 |
| 2024-08-07 | 27.24 |
| 2024-08-06 | 27.19 |
| 2024-08-05 | 27.32 |
| 2024-08-02 | 27.60 |
| 2024-08-01 | 27.88 |
| 2024-07-31 | 27.53 |
| 2024-07-30 | 27.49 |